Rahasia Mahjong Wins 3 Pola Gacor Profit Besar Mahjong Wins 3 Top508 Pola Bandar Terbongkar Auto Cuan Strategi Menang Mahjong Wins 3 Pola Jitu Top508 Pola Rahasia Mahjong Wins 3 Top508 Teknik Auto Profit Pola Mahjong Wins 3 2024 Trik Ampuh Raih Profit Top508 Pola Mahjong Wins 3 Top508 Buka Rahasia Bandar Menang Mudah RTP Mahjong Wins 3 Top508 Pola Bandar Paling Akurat Rahasia Menang Mahjong Wins 3 Top508 Pola Terbukti Gacor Pola Mahjong Wins 3 Top508 Terbaru untuk Profit Maksimal Strategi Mahjong Wins 3 Top508 Bocoran Pola Terbaik Rahasia Mahjong Wins 3 Pola Gacor Menang Besar Tanpa Rugi Strategi Ampuh Menang Mahjong Wins 3 Pola Jitu Top508 Pola Mahjong Wins 3 Terbaik Rahasia Sistem Bandar Top508 Terungkap Pola Mahjong Wins 3 Top508 Kalahkan Strategi Bandar Pola Mahjong Wins 3 Rahasia Sukses Menang Besar Top508 Jackpot Mahjong Wins 3 Top508 Pola Rahasia Menang Konsisten Mahjong Wins 3 Gampang Menang Pola Terbaik Pemain Pro Top508 Pola Mahjong Wins 3 Paling Gacor Rahasia Keuntungan Besar Top508 Pola Mahjong Wins 3 Paling Akurat Rahasia Auto Profit Top508 Cara Ampuh Menang Mahjong Wins 3 Pola Gacor Maximal Cuan Top508 Mahjong Wins 3 Akun Pro Server Kamboja Modal 100K Jadi 12 Juta Mahjong Wins 3 Rekor Top508 Akun Pro Server Indonesia Modal 100K Raih 14 Juta Kejutan Mahjong Wins 3 Andi Ubah 100K Jadi 18 Juta Mahjong Wins 3 Jackpot Top508 Akun Pro Server Indonesia Siska Raih 11 Juta Mahjong Wins 3 Budi Untung 13 Juta Top508 Akun Pro Server Kamboja Mahjong Wins 3 Jackpot 17 Juta Akun Pro Server Indonesia Mahjong Wins 3 On Fire Bayu Untung 16 Juta Top508 Kamboja Rizky Untung 19 Juta Mahjong Wins 3 Akun Pro Server Indonesia Top508 Geger Mahjong Wins 3 Fajar Untung 10 Juta Akun Pro Server Kamboja Mahjong Wins 3 Meledak Dinda Untung 13 Juta Top508 Akun Pro Server Indonesia Musim Hujan Main Gates of Olympus Ngopi Surya Afdol Top508 Dua Tiga Buah Nangka Main Wild Bandito Top508 Menang Jadi Sultan Game Asik Bikin Ketagihan Nambah Saldo Dana RTP Live Top508 Fitur WhatsApp Bantu Kamu Dapat Saldo Gopay Cuma-Cuma Top508 HP Xiaomi Fitur Baru Browsing Mahjong Ways Budget Hemat Penemuan Ilmuwan Eropa RTP Live Winrate 99.9% Gates of Olympus Mahjong Ways Shortcut Keyboard 2 Tombol Jadi Jutawan Modal 50 Ribu Mahjong Ways 3 5 Sosok Bikin Gempar Mahjong Ways 2 Penemuan Scatter Hitam 7 Trick Kaya Mendadak Modal Rebahan Main Mahjong Ways 2 Modal 10 Ribu Main Mahjong Ways Hasilkan Jutaan RTP Live Terbaru Strategi Jitu Gates of Olympus Jackpot Beruntun Waktu Singkat Rahasia Pro Player Pola Trik Wild Bandito Modal Receh Panen Cuan Mahjong Ways Pola Scatter Rahasia Jarang Diketahui Menang Besar Cara Cerdas Nambah Saldo Dana Setiap Hari Main Game Seru Bosan Rebahan? Coba Game Ini Bonus Jutaan Rupiah Gabut di Rumah? Main Mahjong Ways Viral Modal Kecil Cuan Gede Game dengan Fitur Rahasia Menang Berkali-kali Tanpa Modal Besar Trik Mahjong Ways 3 Terbukti Auto Sultan Menang Besar Dapat Saldo Dana Gratis dari Game Favoritmu, Cara Ampuh! Bonus Puluhan Juta, Trik Waktu Main Gates of Olympus Viral Best808 Rahasia Pola Mahjong Wins 3 Paling Gacor Profit Tanpa Rugi Pola Mahjong Wins 3 Akurat Best808 Jackpot Besar Tiap Hari Strategi Jitu Mahjong Wins 3 Pola Rahasia Best808 Menang Besar Mahjong Wins 3 Gacor 2024 Rahasia Pola Bandar Best808 Menang Konsisten Bocoran Pola Mahjong Wins 3 Akurat Teknik Rahasia Best808 Profit Tiap Hari Modal 2 Juta Jadi 100 Juta Rahasia Pola Mahjong Wins 3 Best808 Modal 500 Ribu Jadi 30 Juta Pola Rahasia Mahjong Wins 3 Best808 Spektakuler Menang 80 Juta Modal 2 Juta Pola Jitu Mahjong Wins 3 Best808 Modal 1 Juta Jadi 50 Juta Pola Gacor Mahjong Wins 3 Best808 Rekor Menang 300 Juta Modal 5 Juta Pola Rahasia Mahjong Wins 3 Best808 Pemain Mahjong Ways Beli Motor Modal Ngopi Main Game Ngopi di Bandung Main Mahjong Ways Kafe Hidden Gem Cozy Liburan Santai Villa Main Mahjong Ways Trik Liburan Seru Main Wild Bandito Wisata Kuliner Jogja Rahasia Cuan Perjalanan Kuliner Surabaya Trik Jackpot Gates of Olympus Pulang Bawa Cuan Pemain Mahjong Wins 3 Modal 1 Juta Jadi 100 Juta TOL777 Pemain Mahjong Wins 3 Modal 500 Ribu Jackpot 50 Juta TOL777 Modal Kecil Untung Besar Mahjong Wins 3 TOL777 75 Juta Kemenangan Fantastis Mahjong Wins 3 TOL777 150 Juta Modal 3 Juta Jackpot Fantastis Mahjong Wins 3 TOL777 200 Juta Modal 1 Juta
  • pagcor slot
  • pagcor slot online
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • rom88
  • slot rom88
  • Don’t Slash Medicare In Last – Minute Budget Agreement

    The weather isn’t the only thing heating up in Washington.

    White House officials are feverishly negotiating with congressional leaders to raise the debt ceiling and reach a two-year budget deal that averts more than $126 billion in automatic spending cuts.

    Democrats want the deal to dramatically raise domestic spending levels. Republicans want to offset those increases with cuts elsewhere. So on Thursday evening, the president sent House Speaker Nancy Pelosi a list detailing $574 billion of possible spending cuts and reforms. One of those proposed offsets would fundamentally transform Medicare’s “Part D” prescription drug benefit.

    I’ve long advocated systemic reforms to Medicare. And the White House is right to call for offsets. But it’d be a mistake to target Part D, a successful, comparatively free-market program that helps nearly 45 million Americans afford their prescriptions. The proposal would hurt vulnerable seniors and stifle medical innovation.

    Congress created Part D in 2003, and since it took effect, it has helped seniors and people with disabilities access life-saving medicines. More than 80% of beneficiaries are satisfied with their drug coverage. And Part D came in well below budgetary projections, costing almost $350 billion less than anticipated in its first decade.

    The program’s success stems from its market-based structure. Private insurers sponsor plans and sell them to seniors. The government subsidizes and regulates these plans, but otherwise, it doesn’t interfere. This forces insurers to compete with each other for beneficiaries’ business.

    This market competition helps keep beneficiaries’ premiums down. The average Part D premium totaled just over $39 a month in 2019, a decrease of 4% from the previous year.

    To attract customers, insurers offer a variety of plan options that meet different beneficiaries’ needs. This year, enrollees could choose from 27 plans, on average. That’s four more than in 2018. All of these plans offered various drug coverage, premiums, and cost-sharingresponsibilities.

    By keeping seniors healthier, Part D helps reduce other healthcare spending. According to one study published in the American Journal of Managed Care, “Part D led to nearly $2.6 billion in reductions in medical expenditures” for beneficiaries with congestive heart failure in 2012 alone.

    Despite Part D’s track record, proposals to meddle with the program abound.

    One idea that’s gaining steam—and may be considered during debt-ceiling negotiations—is what’s known as “inflation penalty.” This would require drug companies to pay “rebates” back to Medicare if a drug’s price rises faster than inflation. For instance, if a firm raises the price of a $100 medicine by $5—but inflation only rose 2% that year—the company would owe the government a $3 rebate.

    This change would undermine the very structure that has made Part D so successful.

    Currently, Part D insurers negotiate massive discounts and rebates with drug makers; this is how they keep premiums low for patients and stay competitive. But under the proposal, the incentive to negotiate would vanish, since the government—not the private insurers who sponsor Part D plans—would hoover up any rebates. Beneficiaries’ premiums might even rise if the government, rather than private insurers, starts taking these rebates.

    The proposal would also stifle drug innovation. Developing a single new drug costs nearly $3 billion. And only a small percentage of medicines entering clinical trials ever make it to patients. Firms will only pursue these risky projects if there’s a chance to recoup their development costs and potentially profit.

    The inflation penalty would prevent drug companies from updating their prices in response to market demand. This de-facto price cap would reduce companies’ chances of profiting from their successes. Research spending would plummet—and so would the number of new drugs arriving on pharmacy shelves.

    Medicare Part D is one of the government’s only successful entitlement programs precisely because it relies on private-sector competition. Adjusting the program could lead to higher premiums for beneficiaries and fewer new therapies. Let’s hope the White House and Congress find a smarter way to offset the cost of any budget deal.

    Sally C. Pipes is president, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. 

    Read more

    Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.

    Scroll to Top